Hexo CEO St-Louis out weeks after activist investor sounds alarm
Ottawa-based cannabis producer has seen its share price drop by 58 per cent since the beginning of the year.
Hexo CEO St-Louis out weeks after activist investor sounds alarm
Ottawa-based cannabis producer has seen its share price drop by 58 per cent since the beginning of the year.
Hexo shifting to Nasdaq, adding marketing guru to C-suite as expansion drive ramps up
Cannabis producer is transferring its U.S. listing from the New York Stock Exchange in a move that’s expected to take effect next week.
Cannabis company Hexo reports $20.7M Q3 loss, revenue edges higher
Ottawa-based firm’s net revenue totalled $22.7 million, up from $22.1 million in the same quarter last year.
Hexo strikes $925M deal to buy country’s largest privately held pot producer
Ottawa-based cannabis firm said Friday it will pay $400 million in cash and $525 million in shares for Toronto-based Redecan as it continues to hunt
Hexo eyeing private label strategy as it charts U.S. expansion
CEO of Ottawa-based firm says arrangement would leverage Hexo’s technology to help multi-state operators boost their product quality and margins while lowering costs.
Hexo CEO Sebastien St-Louis said 48North’s strength in topical CBD- and THC-infused creams and ointments was a major selling point as Ottawa firm looks to
Hexo to issue up to $150M in new stock to fund U.S. expansion plans
Ottawa-based pot producer says it also wants to upgrade its plant in Belleville, where it bottles cannabis-infused drinks in a joint venture with brewing giant
Cannabis producer Hexo seeks $1.2B capital raise to fund expansion plans
CEO Sebastien St-Louis said the Ottawa-based company is seeking “maximum flexibility” to make acquisitions and sign partnerships with players in related industries.
Hexo cuts Q2 loss after revenue nearly doubled compared with year ago
Ottawa-based cannabis firm reported a loss of $20.8 million in its latest quarter, compared with a loss of $298.2 million in the same period in 2020.
Hexo to acquire Zenabis in $235M deal, gain European pot market foothold
The companies believe the deal will help Ottawa-based cannabis producer access the European medical cannabis market through Zenabis’ partnerships.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored